Genome Compiler Raises $500K, Eyeing $5M | GenomeWeb

NEW YORK (GenomeWeb News) – Bioinformatics firm Genome Compiler has raised $500,000 toward a targeted round of $5 million, the company said in a document filed with the US Securities and Exchange Commission this week.

The Northern California-based firm did not identify investors in the round or say how the proceeds will be used. In its Form D filed with the SEC, it said that the type of securities offered comprised equity and security to be acquired upon exercise of option, warrant, or other right to acquire security.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.